Table 3.
Impact of Sarcopenia on Transplant Outcomes
| Mager37 | Boster31 | Woolfson33 | Verhagen35 | Takeda36 | Jitwongwai40 | |
|---|---|---|---|---|---|---|
| Age at transplant | ✗ | ✗ | ✗ | |||
| Duration of operation | ✓ | |||||
| Blood loss during transplant | ✓ | |||||
| ICU LOS | ✓ | ✓ | ✓† | ✗ | ||
| Duration of intubation | ✓ | ✗ | ✗ | ✓ | ||
| Vascular complications | ✗ | * | ✗ | ✓ | ✗ | |
| Biliary complications | ✗ | * | ✗ | ✗ | ✗ | |
| Return to OR | ✗ | ✗ | ✓ | |||
| Serious infection | ✗ | ✗ | ✗ | ✓ | ✗ | |
| Hospital LOS | ✓ | ✗ | ✗ | ✓† | ✗ | ✓ |
| Postoperative TPN support | ✗ | |||||
| Long term growth delay | ✓ | |||||
| Readmission | ✓ | ✗ | ||||
| Rejection | ✗ | ✗ | ✗ | ✗ | ||
| Immunosuppression | ✗ | |||||
| Death | ✓ | * | ✗ | ✗ | ✗ |
Notes: ✓: Significant association found (p < 0.05), ✗: No significant association identified (p > 0.05), *Incidence too low for comparison, †Statistically significant but weak. Shaded boxes denote that variable was not asssessed/reported
Abbreviations: ICU, intensive care unit; LOS, length of stay; OR, operating room; TPN, total parenteral nutrition.